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Optimizing Outcomes During Left Main
Percutaneous Coronary Intervention
With Intravascular Ultrasound and
Fractional Flow Reserve
The Current State of Evidence
Rishi Puri, MBBS, Samir R. Kapadia, MD, Stephen J. Nicholls, MBBS, PHD,
James E. Harvey, MD, MSC, Yu Kataoka, MD, E. Murat Tuzcu, MD
Cleveland, Ohio
Percutaneous coronary intervention (PCI) is an evolving indication for the treatment of unprotected left
main coronary arterial (UMLCA) stenoses in selected individuals. Intravascular ultrasound (IVUS)-guided
PCI within the epicardial coronary tree has been shown to improve acute procedural results and sub-
sequent clinical outcomes. Similarly, fractional ﬂow reserve (FFR) is rapidly gaining popularity as a
means to guide the coronary interventionalist to embark upon a “physiological-based” revascularization
strategy. In light of the emergence of PCI for ULMCA stenoses, the lack of randomized trials has meant that
there are no systematic guidelines that advocate the routine use of these adjunctive imaging techniques to
optimize procedural and clinical outcomes. Given the potential dire clinical consequences of procedural
failure during ULMCA PCI, in this review we systematically address the current level of evidence for the use
of FFR and IVUS during the assessment for and undertaking of PCI for ULMCA stenoses. In lieu of the cur-
rent available level of evidence, we recommend the use of FFR for the assessment of (angiographic indeter-
minate) isolated ostial or midshaft left main coronary arterial (LMCA) stenoses in patients who are consid-
ered more appropriate candidates for coronary arterial bypass grafting. In those patients with distal/
bifurcation LMCA lesions and in those with diffuse/distal coronary arterial disease, we strongly recommend
the liberal use of IVUS. Furthermore, in those patients considered likely candidates for ULMCA PCI, IVUS
remains crucial for assessing the degree of lumen compromise and the extent, distribution, and morphol-
ogy of plaque as well as for the immediate postprocedural quantiﬁcation of stent deployment.
(J Am Coll Cardiol Intv 2012;5:697–707) © 2012 by the American College of Cardiology FoundationAlthough once considered a relative contraindica-
tion and widely discouraged, percutaneous coro-
nary intervention (PCI) for unprotected left main
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February 10, 2012, accepted February 18, 2012.coronary arterial (ULMCA) stenosis is now rapidly
emerging as a viable alternative to coronary artery
bypass grafting (CABG), long-considered the stan-
dard of care for such lesion subsets. Collective data
from numerous worldwide registries (1–7) and more
recent results from the randomized SYNTAX (Syn-
ergy Between Percutaneous Coronary Intervention
With Taxus and Cardiac Surgery) trial (8) have
highlighted PCI for UMLCA as a viable alterna-
tive in selected patient groups. Accordingly, PCI
for ULMCA stenosis has had an evolving indica-
tion, with a recent Class IIa (Level of Evidence: B)
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698indication within the latest European guidelines (for iso-
lated left main coronary arterial [LMCA] disease or for
1-vessel disease providing the lesion involves the ostium or
shaft the LMCA segment) (9), slightly ahead of the Class
IIb (Level of Evidence: B) indication stipulated within the
current U.S. guidelines (10). The parallel emergence of
adjunctive imaging tools (intravascular ultrasound [IVUS],
fractional flow reserve [FFR]) has allowed coronary inter-
ventionalists to greatly optimize lesion selection and im-
prove immediate procedural and clinical results (11,12), yet
the routine uptake of such techniques by the interventional
community has been somewhat modest (13). In this review,
we highlight the current state of evidence for the use of
IVUS and FFR during PCI for ULMCA stenoses.
Assessing the True Severity
of LMCA Stenoses:
From Structure to
Physiology
The dissociation between an-
giography (or “lumenography”),
the true extent of plaque burden,
and corresponding physiological
significance of coronary arterial
stenoses has been well-described
(14), none more evident than
within the LMCA segment. Ini-
tial data revealed significant dis-
crepancies between angiographic
estimates of stenosis severity and
findings at autopsy (15). This
was later documented in vivo
with IVUS (16). The uniqueness
of the LMCA segment when
compared with the epicardial
coronary tree ensures that the
simple reliance on angiographic
assessment of lesion severity
might be fraught with inaccu-
racy. Its short-length, the presence of overlapping daughter
branches, the concealment of diffuse atherosclerosis due to
arterial remodeling, the distinct lack of a reference segment,
and issues of catheter placement and contrast “streaming”
for assessing the presence of ostial disease make the accurate
assessment of the LMCA segment notoriously difficult even
by the most experienced of clinicians (Fig. 1). Furthermore,
the LMCA is unique in that it might exhibit reverse
tapering, such that the ostium is of smaller caliber than the
distal section before the origin of daughter branches, despite
the absence of atherosclerosis (17) (Fig. 2). From a clinical
standpoint, the difficulty of simply achieving concordance in
the agreement of lesion severity was highlighted in a
Abbreviations
and Acronyms
DES  drug-eluting stent(s)
FFR  fractional flow
reserve
FU  duration of follow-up
IVUS  intravascular
ultrasound
LAD  left anterior
descending
LCX  left circumflex
LMCA  left main coronary
artery
MACE  major adverse
cardiovascular event(s)
MI  myocardial infarction
MLA  minimum lumen area
MLD  minimum lumen
diameter
PA  pulmonary artery
PCI  percutaneous
coronary intervention
ULMCA  unprotected left
main coronary arterysubanalysis of CASS (Coronary Artery Surgery Study), iwhereby there was only 41% to 59% agreement between
experienced angiographers at a clinical site, a quality control
site, and those on a study consensus panel (18). From a
physiological standpoint, recent studies have highlighted
that correct lesion classification by experienced interven-
tional cardiologists occurs in no 50% of occasions, with
large interobserver variabilities (19,20).
Using FFR to Guide Decision Making
for ULMCA Stenoses
The physiological assessment of epicardial coronary le-
sions(s) via FFR is now well-validated and established as the
invasive “gold-standard” approach in localizing myocardial
ischemia, with a greater specificity than comparative non-
invasive techniques in localizing myocardial ischemia (21).
ince the results of the DEFER (22) and FAME (Frac-
ional Flow Reserve versus Angiography for Multivessel
valuation) (12) trials, the adoption of an FFR-based PCI
trategy has been gaining popularity around the world.
lthough LMCA disease was an exclusion criteria within
he DEFER and FAME trials, FFR has nevertheless been
sed for evaluation of the physiological significance of
ndeterminate ULMCA lesions.
Although underpowered to detect meaningful differences
etween differing patient groups, earlier studies highlighted
he potential for FFR to guide decision making with regard
o the need for revascularization of isolated, angiographi-
ally indeterminate LMCA stenoses (23). Table 1 summa-
izes the results of these similarly designed trials to date,
ith a collective enrollment of 449 patients and a mean
ollow-up period of 29 months (20,24–28). As a whole,
hese data provides support for the utility of an FFR-based
pproach to guide decision making for the management of
ngiographically indeterminate lesions within the LMCA
egment.
However, a number of important caveats of this approach
arrant further consideration. At present, there is a lack of
andomized data from larger multicenter studies confirming
he long-term safety of this approach. Also, as to the use of
FR per se, it remains debatable as to whether an FFR
0.75 versus an FFR of 0.80 should be regarded as the
ppropriate ischemic threshold. Some proponents of the
FR technique to assess LMCA severity suggest the com-
lementary use of IVUS to assess LMCA severity if the
MCA FFR is between 0.80 and 0.85 (29). At least 50% to
0% of ULMCA lesions involve the distal bifurcation, often
ith significant involvement of the ostia of both daughter
ranches. Therefore, an FFR pullback should be undertaken
tarting within both daughter branches to localize the most
ignificant distribution of disease across the region border-
ng the distal LMCA segment and ostia of both daughter
ranches. FFR readings across the LMCA segment will be
nfluenced by the presence of lesions within distal coronary
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699segments as well as the amount of functional myocardial
territory supplied by these lesions (Fig. 3). Stenoses within
the left anterior descending (LAD) or left circumflex (LCX)
territories will artificially increase the FFR measured across
the LMCA stenosis (30), and therefore PCI to these lesions
would unmask the true hemodynamic significance of the
stenosis within the LMCA segment. Recanalization of a
stenotic right coronary artery lesion would also modestly
increase the FFR across a lesion within the left coronary
system (31). Additionally, the inter-individual variation in
hyperemic response is varied (32), and higher doses of
intravenous adenosine might need to be administered to
achieve an optimal response.
Using IVUS to Guide Decision Making
for ULMCA Stenoses
Although the correlation of IVUS measurements with FFR
findings within the epicardial coronary tree are modest
(33–35), the relatively larger size and limited variability of
LMCA length have allowed a greater degree of concordance
between IVUS and FFR for assessing LMCA lesion signif-
Figure 1. Left Main Coronary Artery
The left main coronary artery comes in all shapes and sizes.icance. Abizaid et al. (36) were the first to report theimportance of LMCA lumen dimensions, when IVUS was
used to evaluate the prognostic significance of indeterminate
LMCA lesions over 1 year. Although no formal minimum
LMCA IVUS-derived parameter was defined as a threshold
for predicting clinical outcome, the LMCA minimum
lumen diameter (MLD) on IVUS was the strongest predic-
tor of the rate of major adverse cardiac events (MACE),
whereas the burden of LMCA segment atherosclerosis on
IVUS was not found to be predictive of MACE. There was
a progressive relationship between the degree of MLD
compromise and subsequent MACE rates. Irrespective of
the actual LMCA segment MLD measured on IVUS, the
presence of coronary stenoses in other vessels and/or diabe-
tes mellitus were strong determinants of 1-year MACE. A
subsequent smaller study (37) corroborated the findings of
Abizaid et al. An important caveat to note from these studies
is that MACE were largely driven by revascularization rates,
undertaken at the discretion of the treating clinician.
After this, 2 outcome-based studies were published to
address this issue of concordance between IVUS and FFR
values in angiographically indeterminate LMCA lesions.
Jasti et al. (24) performed sequential FFR and IVUS
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700measurements across angiographically indeterminate
LMCA lesions. Compared with the FFR of 0.75 (across
the LMCA segment) as being the “gold-standard” measure
Figure 2. Ostial Stenosis of the LMCA
A and B show the angiographic projections of what seems to be an ostial ste
administration and a patent mammary graft. However, C (ostial LMCA) and D
lumen area by intravascular ultrasound. Minimum lumen area by intravascular
distal left main region.
Table 1. Summary of FFR-Guided Clinical Outcomes Trials Involving Assess
First Author (Ref. #)
N
Total Defer Group Surgical Group FFR Cu
Bech et al. (23) 54 24 30
Jasti et al. (24) 51 37 14
Jiménez-Navarro et al. (25) 27 20 7
Legutko et al. (26) 38 20 18
Suemaru et al. (27) 15 8 7
Lindstaedt et al. (28) 51 24 27
Hamilos et al. (20) 213 138 75
Total or (mean) 449 271 178
*p NS compared with surgical group.FFR fractional flow reserve; FU duration of follow-up; ULMCA unprotected left main coronary aof functional significance, an MLD of 2.8 mm on IVUS was
found to have the highest sensitivity and specificity (93%
and 95%, respectively) for identifying the true functional
f the left main coronary artery (LMCA), despite intracoronary nitroglycerine
LMCA) show no signiﬁcant atherosclerosis and signiﬁcantly smaller ostial
ound at the left main ostium was 11.4 mm2 compared with 24.2 mm2 at the
and Treatment Decision Making for ULMCA Stenoses
Overall Survival
alue FU (Months) Mean Duration Defer Group (%) Surgical Group (%)
29 15 100 97
25 11 100 100
26 12 100 86
24 12 100 89
33 10 100 100
29 16 100 81
35 12 90 85
(28 13) (95)* (89)nosis o
(distal
ultrasment
toff V
0.75
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0.75
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701significance of the ULMCA stenosis. This was followed by
minimum lumen area (MLA) on IVUS of 5.9 mm2 (93%
sensitivity, and 95% specificity). Patients with a ULMCA
segment FFR 0.75 underwent revascularization of this
segment, compared with patients whose ULMCA seg-
ment FFR reading was 0.75, who remained on medical
therapy, unless revascularization of an epicardial coronary
lesion was required. The 38-month Kaplan-Meir survival
estimates for both FFR groups (0.75 and 0.75) were
100% (p  NS) (24).
More recently, Kang et al. (38) investigated 55 patients
with isolated UMLCA stenoses (30% to 80% diameter
stenosis severity) that underwent IVUS and FFR before
intervention. The only independent predictor of an FFR
0.80 was the LMCA lesion MLA on IVUS (adjusted
odds ratio: 0.312, p  0.001). An MLA on IVUS of 4.8
mm2 was found to best predict an FFR 0.80 (89%
Figure 3. Tandem Lesion Downstream
This type of lesion will mask the true hemodynamic signiﬁcance of the left
main coronary artery lesion by compromising hyperemic ﬂow and subse-
quent true maximal pressure gradient across this lesion. After percutaneous
coronary intervention to the distal lesion, hyperemic blood ﬂow through
the vessel has increased, hence the true fractional ﬂow reserve (FFR) of the
left main coronary artery lesion becomes apparent.ensitivity, 83% specificity). Greater lesion length on an- aiography was also found to be associated with functional
ignificance. As such, the dynamic relationship between
esion length, MLA (by IVUS), and FFR remains under
nvestigation. It is likely that longer, diffuse lesions with
arger IVUS-derived MLA might be ultimately found to
arbor greater physiological significance than short, focal
esions with lesser MLAs. The clinical implications of these
elationships are also uncertain.
In the absence of corresponding physiological measure-
ents, IVUS-based criteria of ULMCA lumen compromise
er se have been successfully used to solely guide clinical
ecision making. Fassa et al. (39) identified the “normal”
ange of ULMCA MLA values as those that were confined
o within 2 SD on either side of the mean of ULMCA
LA sampled from 121 consecutive patients with angio-
raphically normal ULMCA lesions at their institution.
ccordingly, the lower range of normal ULMCA MLA
quated to 7.5 mm2 in their population sampled (39). After
his, 214 patients with angiographically ambiguous
LMCA lesions underwent IVUS. Of the patients with a
LMCA segment IVUS MLA 7.5 mm2, 87% were
treated medically, whereas 86% of patients with an MLA
7.5 mm2 were revascularized. All patients were followed
for a mean period of 3.3 years, and no statistical differ-
ence in outcomes was found between these 2 patient
groups.
A recently published study evaluated the safety of a lower
predefined IVUS MLA threshold of 6 mm2 to guide
decision making in a prospective multicenter study (40). An
IVUS-derived ULMCA segment MLA of 6 mm2 was
previously shown to be a much closer IVUS (structural)
correlate of an FFR of 0.75 across an angiographically
indeterminate ULMCA lesion (24) and hence thought to
be a more representative and appropriate threshold on
IVUS. Accordingly, a total of 354 patients were enrolled in
22 centers. In 179 patients with a ULMCA segment MLA
of 6 mm2, revascularization was deferred (although per-
itted for non-ULMCA lesions), whereas the remaining
52 patients with an MLA 6 mm2 were revascularized
(45% with PCI and 55% with CABG). Importantly, the
2-year event-free survival of cardiac death and myocardial
infarction (MI) was 97.7% in those patients who had no
ULMCA revascularization, compared with 94.5% in the
revascularized group (p 0.5) (40). The results of this study
provide further support for the utility of IVUS alone in
guiding an appropriate treatment strategy for patients with
angiographically indeterminate ULMCA stenoses. Al-
though an MLA of 6 mm2 was shown to be a valid cutoff for
linical decision making, yielding acceptable long-term
linical results, it is conceivable that lower MLA cutoff
alues might ultimately be shown to yield similarly accept-
ble long-term clinical outcomes (Table 2).
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702True Distribution of LMCA Plaque:
Insights From IVUS
Intravascular ultrasound has recently been used to highlight
the complexity of distribution, burden, and composition of
atherosclerotic plaque within the LMCA segment. A sound
appreciation of these factors is crucial for planning and
executing the optimal approach for PCI of the ULMCA
lesion at hand. The length of the LMCA segment has been
found to be an important factor in determining the predom-
inant distribution of plaque, such that longer-length (10
mm) LMCA segments have been shown to harbor signifi-
cantly more plaque burden within the distal bifurcation
region, compared with shorter (10 mm) LMCA segments
that harbor a slightly greater preponderance for plaque to
distribute at the LMCA ostium (41). This study also
revealed ostial LMCA lesions to have less overall plaque
burden, greater degrees of negative (constrictive remodel-
ing) and less calcification than nonostial LMCA lesions.
Percutaneous coronary intervention of bifurcation
ULMCA lesions have traditionally posed a greater chal-
lenge for achieving MACE rates similar to those achieved
with PCI of ostial ULMCA lesions (42). Although this
might in part be a reflection of the stenting technique (43)
and/or limitations of contemporary stent technologies (44),
a lack of appreciation of the true extent, morphology, and
true distribution of the LMCA bifurcation plaque within
both daughter branches (LAD and LCX) is also a critical
factor. Oviedo et al. (45) recently highlighted the inaccuracy
of angiography alone for classifying LMCA bifurcation
lesions. Contrary to findings upon angiography, IVUS
identified the diffuse nature of atherosclerosis involving not
only the parent (LMCA) segment but also both flow
dividers (LAD and LCX). Although the carina was always
Table 2. Summary of Studies Using IVUS to Determine the Significance of
First Author (Ref. #) N
FU
(Months) Outcome
Abizaid et al. (36) 122 12 MACE
Ricciardi et al. (37) 107 29 MACE
Legutko et al.* 44 44 Ischemia
Jasti et al. (24) 51 11 Ischemia
Fassa et al. (39) 214 40 MACE
de la Torre Hernandez et al. (40) 354 24 MACE
Kang et al. (38) 55 NA Functional
*Legutko J, Dudek D, Rzeszutko L, Hubalewska A, Wizimirski M, Dubiel J. Invasive assessment
2004;25:429(P2425).
IVUS intravascular ultrasound; LMCA leftmain coronary artery; MACEmajor adverse card
in Table 1.spared, continuous plaque from the LMCA segment to the Mproximal LAD was seen in 90% and in 62% of occasions to
the proximal LCX segment (45). Bulky calcification might
preclude appropriate lesion modification before stent im-
plantation, which inevitably leads to stent under-
deployment. On IVUS, the independent predictors of
LMCA segment calcification were found to be related to
prior CABG (protected LMCA segments), increasing age,
Caucasian race (vs. Asian), and bifurcation location (46).
dditionally, radio frequency analysis of IVUS data has
hown that the ostial/proximal segment of the LAD con-
ains greater amounts of complex (necrotic core and calci-
cation) plaque than the LMCA segment itself; however,
his requires further validation (46). Finally, in the setting of
istal/bifurcation LMCA lesions, the importance of con-
ucting dual IVUS pullbacks from within both the LAD
nd LCX branches has been highlighted (47). This is due to
he relative inaccuracy of assessing lumen dimensions within
he side branch ostium with IVUS (which significantly
verestimates real lumen diameters) from the main vessel,
ompared with the direct assessment of each side branch
espectively.
Intravascular ultrasound also plays a pivotal role in
ssessing plaque shift, especially after PCI of distal/
ifurcation ULMCA lesions, and is also critical for the
ptimization of post-procedural MLA after PCI to reduce
estenosis rates. It has been shown that, irrespective of the
echnique used for stenting bifurcation lesions with drug-
luting stents (DES), the commonest site of restenosis
nvariably occurs at the ostium of the side-branch (43),
hereby the final post-intervention MLA at the ostium of
he LCX branch was the only significant predictor of
estenosis. For those patients who underwent a single
rossover stent strategy, a post-intervention ostial LCX
A Disease
US Criterion for
Significance Comment
MLD No speciﬁc cutoff suggested. LMCA MLD 3 mm portends
incremental risk, also determined by comorbidities and
coronary artery disease in other territories
MLA No speciﬁc cutoff suggested. MLA was a predictor of
cardiac events
MLD, MLA MLA 8 mm2 and MLD 2.8 mm correlated with FFR
0.75 and ischemia on 99Tc-Mibi-Spect
MLD, MLA MLA 5.9 mm2 and MLD 2.8 mm. FFR of 0.75
used as gold-standard reference
MLA MLA 7.5 mm2
MLA MLA 6 mm2
FFR IVUS-derived MLA of 4.8 mm2 correlated with FFR 0.80
borderline left main coronary artery stenosis—comparison with 99Tc-MIBI SPECT. Eur Heart J
lar events; MLAminimum lumen area; MLDminimum lumen diameter; other abbreviations asULMC
IV
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iovascuLA of 4 mm2 was associated with a restenosis rate of
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7036% compared with 50% in those whose ostial LCX MLA
was 4 mm2 (p  0.04). Similarly in those who received 2
tents, a post-intervention ostial LCX MLA of 5.5 mm2
was associated with a restenosis rate of 15% compared with
67% in those whose ostial LCX MLA was 5.5 mm2 (p 
.03). Although no published data currently exist for de-
cribing the optimal post-procedural MLA of the LMCA
ain-branch, expert consensus would recommend post-
ilating the main branch to 8.5 mm2 to reduce the rate of
arget lesion revascularization, while aiming for an MLA of
5.5 mm2 for the ostia of each daughter branch (48).
Does the Use of IVUS-Guided PCI Within the
ULMCA Segment Improve Clinical Outcomes?
Despite suggestive evidence to the contrary, there is still a
general consensus within the interventional cardiology com-
munity that IVUS-guided stent implantation has a limited
role in routine daily practice for demonstrating clinical
benefit. As such, in North America, the general rate of
IVUS use has struggled to climb beyond 10% of all PCIs
performed (13). The use of IVUS to optimize lesion dilation
was first proven to be clinically beneficial during the plain
old balloon angioplasty era (49,50). After this, a number of
trials demonstrated immediate procedural and clinical ben-
efits of an IVUS-guided approach during PCI (51–56).
However, the advent of DES with accompanying observa-
tions of remarkably low rates of in-stent restenosis perhaps
contributed to the stifling of the emerging enthusiasm to
undertake IVUS-guided PCI. Almost fittingly, however,
IVUS proved crucial for understanding the mechanisms of
stent thrombosis (and restenosis) that were observed after
suboptimal DES deployment as well as using longer stents
(57–59). Accordingly, IVUS guidance during DES implan-
tation has been found to significantly reduce stent throm-
bosis rates and the need for repeat revascularization (11) as
well as the short-term (30 days) and long-term (2 years) rate
of death and MI, with similar evidence of benefit found
during complex bifurcation stenting (60).
There is a dearth of appropriately designed studies
examining whether similar benefit is derived during PCI of
ULMCA segments. The lack of a systematic randomized
trial has meant that the current level of evidence exists from
retrospective analysis of registry data coupled with expert
opinion. Initial comparisons between differing centers fo-
cusing on the effect of IVUS-guided ULMCA PCI yielded
conflicting results. Agostoni et al. (61) showed no long-term
clinical benefit of IVUS-guided ULMCA in 58 patients,
whereas Park et al. (62) showed clear 1-year reductions in
MACE in 102 patients. In a similar fashion, both centers
have recently reported vastly differing rates of long-term
clinical outcomes after ULMCA PCI (4-year all-cause
mortality 35% in Onuma et al. [63] study vs. 6% in Park et
al. [64] study). A closer analysis of these respective cohortsreported from each center reveal important differences in
patient and procedural characteristics that no doubt con-
tributed to the vastly differing clinical outcomes. Onuma et
al. (63) included patients that were older (65 vs. 61 years)
and had worse left ventricular function (45% vs. 59%) and
significantly higher operative risk (SYNTAX score of 39 vs.
Euroscore of 3.3 in Park et al. [64]) and also included
patients in cardiogenic shock (9% vs. 0%) or had an acute
MI (23% vs. 0%), compared with the comparative results
presented by Park et al. Importantly, Park et al. report a
90% rate of IVUS-guided ULMCA PCI compared with
30% in the cohort described by Onuma et al. Collectively,
these results suggest an influence of patient comorbidities
and procedural characteristics upon long-term outcomes
after ULMCA PCI.
The most comprehensive data published to date on
whether IVUS-guided ULMCA PCI yields superior clini-
cal outcomes than angiography-guided ULMCA PCI stems
from a post-hoc analysis from the MAIN-COMPARE
(Revascularization for Unprotected Left Main Coronary
Artery Stenosis: Comparison of Percutaneous Coronary
Angioplasty vs Surgical Revascularization) registry in which
nonrandomized long-term clinical outcomes were evaluated
in 975 patients (65). To account for the significant baseline
differences between the 2 patient groups, propensity score
matching was used to identify 201 “comparable” pairs of
patients in each group. Kaplan-Meier incidence curves of
log-rank 3-year outcomes revealed a significant lowering of the
cumulative mortality rate within the IVUS-guided ULMCA
PCI group receiving DES compared with the angiography-
guided group (4.7% vs. 16%, p  0.048). However, on
multivariate analysis in all-comers (those receiving bare-
metal stent and DES), there was a strong trend toward a
statistically significant reduction in the rate of death at 3
years (hazard ratio: 0.54, 95% confidence interval: 0.28 to
1.03, p  0.061).
Although these data suggest at the very least a marginal
statistical clinical benefit of using IVUS-guided elective
ULMCA PCI, there are some important limitations of this
study worthy of mention. The inherent flaws of a nonran-
domized study inevitably result in the real possibility of
results being influenced by unmeasured confounders. More-
over, it seems that the study was not sufficiently powered to
adequately compare the effectiveness of the 2 PCI strategies.
Differences in acute procedural stent/vessel characteristics
between the 2 groups were not reported. With an IVUS-
guided PCI strategy, it would not be unreasonable to expect
to see systematic reductions in target lesion revasculariza-
tion; however, this was not observed. As such, the under-
lying mechanism for the observed reductions in mortality in
this study remains elusive.
More recent data from Kang et al. (66) have shed some
further light on the importance of evaluating the IVUS-
derived MLA within the region of the distal LMCA
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704segment and origin of both daughter branches (termed
“polygon of confluence,” or POC) with IVUS before and
after PCI. In the 168 patients with ULMCA segment
bifurcation lesions undergoing PCI with 42 months of
follow-up, the pre-PCI polygon of confluence MLA (a
surrogate of the burden of distal LMCA disease) was an
important predictor of the subsequent post-PCI minimal
stent area that was achieved, which was also an important
predictor of clinical events during follow-up. These data
underscore the importance of performing optimal lesion
preparation with IVUS-guidance before stent deployment
for distal ULMCA lesions.
Summary and Author Recommendations
There is no other segment within the human coronary
vasculature that is subject to such a significant degree of
interobserver variability when assessing the degree of lumen
compromise than the LMCA segment. Consequently,
IVUS or FFR are strongly recommended when clinical
suspicion arises as to the real significance of disease within
the LMCA segment. It should be emphasized that the
utility of these tools and the additional information gleaned
from these invasive modalities should be carefully placed
into the appropriate context with regard to patient clinical
presentation. Fractional flow reserve provides a true in vivo
determination of the physiological significance of LMCA
lesions, without any information on structural extent and
distribution of disease. Short of a large-scale randomized
trial, there is emerging validation of its long-term safety and
appropriateness for guiding decision making for angio-
graphically indeterminate ULMCA stenoses. However,
caution needs to be applied when using this technique in the
setting of diffuse downstream as well as remote coronary
arterial disease, because these will inevitably influence the
FFR across the ULMCA segment per se. It is also impor-
tant to emphasize that intravenous adenosine should be
used for stimulating hyperemia, with an appropriate pull-
back recording undertaken to allow localization of the
disease within the LMCA segment or within daughter
vessels. For evaluation of ostial LMCA lesions, care must be
taken to disengage the guiding catheter during FFR mea-
surements to prevent pressure dampening and an artificial
increase in the FFR measurement obtained. Distal/
bifurcation ULMCA stenoses require a dual FFR pullback.
Furthermore, for FFR values within the gray-zone of 0.75
to 0.80, many experts would recommend the adjunctive
use of IVUS in this setting. As such, FFR might be more
suited for the evaluation of true ostial LMCA stenoses. If
PCI is chosen as the likely mode of ULMCA revascu-
larization, then we strongly recommend the use of IVUS,
particularly for guiding the appropriate interventional
strategy with immediate post-PCI evaluation of adequacy
of stent deployment.The strongest, most consistent LMCA segment param-
eter on IVUS that correlates with an FFR threshold of
0.75 and clinical outcomes is an IVUS-derived LMCA
segment MLD threshold of 2.8 mm. An IVUS-derived
MLA of 5.9 mm2 also correlated with an FFR threshold of
0.75. Moreover, an IVUS-derived MLA of 6 mm2 has
een shown to an acceptable cutoff for guiding an LMCA
esion revascularization strategy. Therefore, on the basis of
he published data to date, it seems reasonable to recom-
end an MLA of 6 mm2 or an MLD of 2.8 mm as the
esignated IVUS-derived thresholds for specifically identi-
ying prognostically significant LMCA segment disease and
hus guiding treatment strategy. Although more recent
eports would suggest an MLA of 6 mm2 as being a
onservative estimate of true functional significance of the
LMCA stenosis (38), such associations still warrant pro-
pective clinical follow-up in a larger cohort of patients. We
ould also like to point out that, ultimately, patient comor-
idities and the overall burden of atherosclerosis in other
oronary territories strongly influence clinical outcomes,
ver and above a precise IVUS-derived threshold for
LMCA significance.
From a technical viewpoint, once the assessment and
ecision for PCI of the ULMCA segment lesion has been
ade, we recommend IVUS pullbacks to occur within both
aughter branches when diffuse or distal LMCA disease is
resent. The smallest direct MLA/MLD of the distal
LMCA segment and ostia of each daughter branch should
e noted. Careful attention should also be made to the
egree of calcification present, and strong consideration
hould be given to plaque modification techniques if
ircumferential calcium is present. For distal/bifurcation
LMCA lesions, every effort should be made to achieve the
reatest possible lumen dimensions before stent deploy-
ent, and iterative post-dilation should be performed to
chieve a minimum stent area of 8.5 mm2, origin LAD
5.5 mm2, and origin LCX 5.5 mm2 (48). It is also
mperative for the guiding catheter to be positioned in a
oaxial fashion to optimize the accuracy of IVUS param-
ters obtained. To better define the true position of the
stium for accurate stent positioning, the IVUS trans-
ucer can also be used in such a way to obtain the optimal
ngiographic view for stent deployment and appropriate
arking of the exact positions of interest (Fig. 4: IVUS
arking of the LMCA ostium with the “Sepal” wire
echnique) (67).
onclusions
It is highly unlikely that there will ever be a randomized
trial designed to test the efficacy of IVUS-guided PCI of
ULMCA stenoses. The eagerly anticipated results of the
EXCEL (Evaluation of Xience Prime versus Coronary
Artery Bypass Surgery for Effectiveness of Left Main
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705Revascularization) trial will help further ascertain the
utility of IVUS-guided PCI for ULMCA lesions. Exist-
ing trials point to the improvement of procedural and
clinical outcomes when IVUS is used to optimize PCI
within the epicardial coronary tree. For ULMCA PCI,
however, the existing level of evidence for using IVUS-
guided PCI is less robust. Nevertheless, the cumulative
weight of existing data coupled with expert opinion
would suggest that adjunctive imaging techniques (IVUS
and/or FFR) be used liberally to assess the underlying
significance of ambiguous ULMCA lesions on angiography.
Furthermore, given the potential dire clinical consequences
of procedural failure resulting in stent thrombosis or reste-
nosis within the ULMCA segment, IVUS-guidance should
be strongly recommended as the standard of care during
Figure 4. “Sepal” Wire Technique
The “Sepal” wire technique for aorto-ostial left main coronary artery (LMCA) st
LMCA compression by the pulmonary artery (PA). (A) An additional workhorse
cular ultrasound marking of the true ostium taking place (white asterisk). (B)
the LMCA. The “Sepal” wire enables the guiding catheter to be withdrawn from
tomical landmarks. Additionally, ﬁne positioning of the stent can be undertake
from being “sucked” into the LMCA when one pulls back with the stent to cov
ultrasound marking).ULMCA PCI.Acknowledgments
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